Press release
Free for publication on October 11, 2018 at 11am (CEST +1)
Oulu, Finland, October 11, 2018 – Bittium together with Cerenion exhibit their innovative products and solutions for intensive care and neurology at the 31st annual congress of the European Society of Intensive Care Medicine (ESICM Lives 2018) on October 21-24 in Paris, France. The annual congress holds a premier spot as the meeting place for medical professionals and industry in the field of intensive care medicine. The congress, consisting of a strong scientific program, a well-attended industry exhibition and a range of training sessions is expected to again attract an audience of over 6,000 physicians, anesthetists, trainees and nursing and allied health professionals from around 100 countries all across the world.
At the event Bittium and Cerenion will present a comprehensive solution being developed in collaboration for monitoring the electrical activity of the brain (EEG) of intensive care patients. This is done by combining Bittium BrainStatus™, a wireless EEG-monitoring device designed for monitoring real-time electrical brain activity, with Cerenion’s innovative C-Trend™ analysis that helps to interpret the brain function of intensive care patients using one simple C-Trend™ Index, which is easy to follow. The purpose of the solution is to ease and speed up the work of the nursing staff at the intensive care unit.
Products and solutions exhibited at the event are:
Bittium’s products and solutions are exhibited at stand 3.27.
More information on the offering: https://www.bittium.com/products__services/medical
Further information:
Arto Pietilä
Senior Vice President, Medical Technologies
Tel. +358 40 344 3507
Distribution:
Main media
Bittium
Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. Bittium also offers healthcare technology products and services for the measurement of and monitoring of biosignals in the areas of cardiology, neurology, rehabilitation, occupational health and sports medicine. Net sales in 2017 were EUR 51.6 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com